Low frequency of flares during pregnancy and post-partum in stable lupus patients

被引:42
作者
Davis-Porada, Julia [1 ]
Kim, Mimi Y. [2 ]
Guerra, Marta M. [1 ]
Laskin, Carl A. [3 ,4 ]
Petri, Michelle [5 ]
Lockshin, Michael D. [1 ,6 ]
Sammaritano, Lisa R. [1 ,6 ]
Branch, D. Ware [7 ,8 ]
Sawitzke, Allen [8 ]
Merrill, Joan T. [9 ,10 ]
Buyon, Jill P. [11 ]
Salmon, Jane E. [1 ,6 ]
机构
[1] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA
[2] Albert Einstein Coll Med, New York, NY USA
[3] Mt Sinai Hosp Toronto, Toronto, ON, Canada
[4] Trio Fertil, Toronto, ON, Canada
[5] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[6] Weill Cornell Med, New York, NY USA
[7] Intermt Healthcare, Salt Lake City, UT USA
[8] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA
[9] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[10] Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA
[11] NYU, Sch Med, 550 1st Ave, New York, NY 10016 USA
基金
美国国家卫生研究院;
关键词
SLE; Pregnancy; Flares; DISEASE-ACTIVITY; ERYTHEMATOSUS; OUTCOMES;
D O I
10.1186/s13075-020-2139-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Lupus patients are at risk for pregnancy loss, and it has been generally accepted that women with SLE should have low disease activity prior to conception. However, there are conflicting results regarding the effect of pregnancy on SLE flares. This study aims to identify predictors of flares during and after pregnancy in SLE patients with inactive or stable disease activity during the first trimester and to characterize and estimate the frequency of post-partum flares in these patients. Methods SLE patients in the multicenter, prospective PROMISSE (Predictors of Pregnancy Outcome: Biomarkers in Antiphospholipid Antibody Syndrome and Systemic Lupus Erythematosus) study were evaluated for flares during and after pregnancy using the SELENA-SLEDAI Flare Index. Flares during pregnancy were assessed in all 384 patients and post-partum flares in 234 patients with study visits 2-6 months post-partum. Logistic regression models were fit to the data to identify independent risk factors for flare. Results During pregnancy, 20.8% of patients had mild/moderate flares and 6.25% had severe. Post-partum, 27.7% of patients had mild/moderate flares and 1.7% had severe. The mild flares rarely required treatment. Younger age, low C4 and higher PGA at baseline were independently associated with higher risk of having at least one mild/moderate or severe flare during pregnancy. Older patients were at decreased risk of flare, as well as those with quiescent disease at baseline. No variables evaluated at baseline or the visit most proximal to delivery was significantly associated with risk of flare post-partum. Medications were not associated with flare during or after pregnancy. Conclusion In patients with inactive or stable mild disease activity at the time of conception, lupus disease flares during and after pregnancy are typically mild and occur at similar rates. Flares during pregnancy are predicted by the patients' age and clinical and serological activity at baseline.
引用
收藏
页数:8
相关论文
共 15 条
[1]   Predictors of Pregnancy Outcomes in Patients With Lupus A Cohort Study [J].
Buyon, Jill P. ;
Kim, Mimi Y. ;
Guerra, Marta M. ;
Laskin, Carl A. ;
Petri, Michelle ;
Lockshin, Michael D. ;
Sammaritano, Lisa ;
Branch, D. Ware ;
Porter, T. Flint ;
Sawitzke, Allen ;
Merrill, Joan T. ;
Stephenson, Mary D. ;
Cohn, Elisabeth ;
Garabet, Lamya ;
Salmon, Jane E. .
ANNALS OF INTERNAL MEDICINE, 2015, 163 (03) :153-+
[2]   Assessing disease activity in SLE patients during pregnancy [J].
Buyon, JP ;
Kalunian, KC ;
Ramsey-Goldman, R ;
Petri, MA ;
Lockshin, MD ;
Ruiz-Irastorza, G ;
Khamashta, M .
LUPUS, 1999, 8 (08) :677-684
[3]   Maternal and fetal outcomes of 72 pregnancies in Argentine patients with systemic lupus erythematosus (SLE) [J].
Cavallasca, Javier A. ;
Laborde, Hugo A. ;
Ruda-Vega, Hilda ;
Nasswetter, Gustavo G. .
CLINICAL RHEUMATOLOGY, 2008, 27 (01) :41-46
[4]   The impact of increased lupus activity on obstetric outcomes [J].
Clowse, MEB ;
Magder, LS ;
Witter, F ;
Petri, M .
ARTHRITIS AND RHEUMATISM, 2005, 52 (02) :514-521
[5]   Hydroxychloroquine in lupus pregnancy [J].
Clowse, Megan E. B. ;
Magder, Laurence ;
Witter, Frank ;
Petri, Michelle .
ARTHRITIS AND RHEUMATISM, 2006, 54 (11) :3640-3647
[6]   The Clinical Utility of Measuring Complement and Anti-dsDNA Antibodies During Pregnancy in Patients with Systemic Lupus Erythematosus [J].
Clowse, Megan E. B. ;
Magder, Laurence S. ;
Petri, Michelle .
JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) :1012-1016
[7]   Effect of pregnancy on disease flares in patients with systemic lupus erythematosus [J].
Eudy, Amanda M. ;
Siega-Riz, Anna Maria ;
Engel, Stephanie M. ;
Franceschini, Nora ;
Howard, Annie Green ;
Clowse, Megan E. B. ;
Petri, Michelle .
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (06) :855-860
[8]   Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [J].
Hochberg, MC .
ARTHRITIS AND RHEUMATISM, 1997, 40 (09) :1725-1725
[9]   PREGNANCY DOES NOT CAUSE SYSTEMIC LUPUS-ERYTHEMATOSUS TO WORSEN [J].
LOCKSHIN, MD .
ARTHRITIS AND RHEUMATISM, 1989, 32 (06) :665-670
[10]  
MINTZ G, 1986, J RHEUMATOL, V13, P732